Stock listing

KRX:456160 G2GBIO, Inc. (지투지바이오) 주가

Follow G2GBIO, Inc. into a list and get an email when it puts out news.

Share price · KRX:456160

₩36,350 KRW +2,750 (+8.2%)

Close on Nov 20, 2026

Past year -61.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩32,900 – ₩38,650 KRWNov 20, 2026
Volume
393,941 sharesNov 20, 2026
Market cap
₩604.5B KRWAt the close on Nov 20, 2026 · price × 16.63M shares outstanding
52-week range
₩22,400 – ₩124,000 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩10.96B KRWMedian day 189,417 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
G2GBIO, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:456160 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩36,350+2,750+8.2%₩33,050₩38,650₩32,900393,941
₩33,600+1,500+4.7%₩32,450₩36,250₩32,150161,693
₩32,100-800-2.4%₩32,200₩32,900₩30,300185,822
₩32,900-2,000-5.7%₩34,850₩35,600₩32,75097,629
₩34,900-1,200-3.3%₩35,500₩38,300₩34,250231,928
₩36,100-1,050-2.8%₩36,850₩37,800₩35,350147,739
₩37,150+2,050+5.8%₩34,950₩38,350₩34,700207,188
₩35,100+4,050+13.0%₩32,150₩35,900₩31,450287,372
₩31,050+850+2.8%₩29,800₩31,350₩28,000258,392
₩30,200-3,650-10.8%₩30,450₩31,000₩29,150334,674
₩33,850+2,100+6.6%₩34,200₩37,150₩33,350653,139
₩31,750-700-2.2%₩32,100₩32,800₩29,350375,039
₩32,450-3,750-10.4%₩35,700₩35,700₩32,100291,722
₩36,200+600+1.7%₩36,100₩38,200₩35,850285,371
₩35,600-1,000-2.7%₩36,950₩37,300₩34,500205,829
₩36,600-1,300-3.4%₩39,800₩40,600₩35,850394,695
₩37,900-1,250-3.2%₩38,400₩40,250₩36,650661,061
₩39,150-6,050-13.4%₩46,000₩46,000₩38,9001,085,582
₩45,200-4,500-9.1%₩48,700₩52,200₩44,200580,992
₩49,700+8,500+20.6%₩42,050₩50,600₩41,1501,308,334
₩41,200-900-2.1%₩41,100₩45,200₩40,250669,818
₩42,100+5,100+13.8%₩42,500₩45,000₩41,4001,125,446
₩37,000+4,800+14.9%₩38,000₩39,200₩34,500652,011
₩32,200+1,050+3.4%₩29,850₩32,350₩29,500104,227
₩31,150+600+2.0%₩30,600₩33,650₩30,200151,551
₩30,550-2,300-7.0%₩30,800₩32,100₩29,750165,664
₩32,850-300-0.9%₩33,550₩34,050₩32,150116,796
₩33,150-4,350-11.6%₩36,150₩36,150₩32,300312,730
₩37,500-4,500-10.7%₩41,700₩42,900₩37,100247,683
₩42,000-2,700-6.0%₩43,150₩44,800₩40,700205,775
₩44,700+800+1.8%₩44,550₩45,150₩42,700264,507
₩43,900+300+0.7%₩43,200₩44,300₩41,050268,329
₩43,600+100+0.2%₩42,800₩44,250₩42,400276,910
₩43,500+8,150+23.1%₩35,250₩45,150₩34,650672,572
₩35,350+1,450+4.3%₩34,450₩35,950₩33,350123,562
₩33,900-850-2.4%₩34,350₩34,950₩33,150129,410
₩34,750+2,700+8.4%₩32,400₩36,350₩32,050297,931
₩32,050+150+0.5%₩31,900₩33,400₩31,90081,131
₩31,900-200-0.6%₩32,150₩32,500₩31,55097,411
₩32,100+200+0.6%₩32,050₩32,550₩31,75065,601
₩31,900-1,100-3.3%₩32,700₩33,000₩31,500162,999
₩33,00000.0%₩33,000₩34,050₩32,55090,024
₩33,000-1,500-4.3%₩33,700₩34,700₩32,500191,089
₩34,500+2,900+9.2%₩36,250₩38,900₩33,700851,128
₩31,600-1,400-4.2%₩32,050₩32,700₩31,400129,182
₩33,000-1,200-3.5%₩32,800₩33,350₩32,300125,216
₩34,200-800-2.3%₩34,500₩34,950₩32,300178,718
₩35,000-2,250-6.0%₩36,600₩37,150₩35,000191,907
₩37,250-1,050-2.7%₩38,100₩39,900₩37,25080,116
₩38,300+350+0.9%₩38,250₩39,300₩37,55048,458
₩37,950+2,050+5.7%₩36,050₩38,350₩35,75074,023
₩35,900-1,150-3.1%₩37,550₩38,100₩35,30065,319
₩37,050-1,550-4.0%₩37,400₩39,900₩36,700117,055
₩38,600-2,750-6.7%₩40,850₩41,100₩38,100136,010
₩41,350-2,300-5.3%₩42,150₩42,150₩39,250193,380
₩43,650+2,400+5.8%₩41,650₩43,950₩39,800151,038
₩41,250-500-1.2%₩40,600₩42,000₩40,000113,256
₩41,750+4,250+11.3%₩38,000₩42,100₩37,500187,744
₩37,500-450-1.2%₩37,700₩37,800₩35,250102,059
₩37,950+550+1.5%₩37,550₩40,400₩37,500155,539
₩37,400-3,550-8.7%₩40,500₩40,500₩36,850109,585
₩40,950-100-0.2%₩43,350₩43,950₩40,750119,721

Splits

1 split · KRX:456160 · every price before a split is adjusted for it

DayRatioWhat
3-for-1Split
Ticker
KRX:456160
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

G2GBIO, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
Decks
1 deck · latest Apr 20, 2026

Valuation

EV/sales 176× against a median of 16.2×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩389.0B KRW
P/E
Loss
EV/sales
176×
EV/EBITDA
Negative EBITDA
Price/book
4.3×
Gross margin
36.2%
Operating margin
−568.7%
Net margin
−793.7%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
G2GBIO, Inc. · KRX:456160US$451.8MUS$290.8Mn/a176×n/a4.3×−793.7%0.0×n/a
BlossomHill Therapeutics, Inc. · NASDAQ:BLSMUS$461.2MUS$259.4Mn/an/an/a2.2×n/a0.1×n/a
Neurogene Inc. · NASDAQ:NGNEUS$458.5MUS$106.4Mn/an/an/a1.3×n/a0.0×1.47
Assembly Biosciences, Inc. · NASDAQ:ASMBUS$454.4MUS$142.3Mn/a2.1×n/a1.5×−16.6%0.0×1.00
Shattuck Labs, Inc. · NASDAQ:STTKUS$454.2MUS$260.4Mn/an/an/a2.4×n/a0.0×1.10
DiaMedica Therapeutics Inc. · NASDAQ:DMACUS$445.1MUS$410.4Mn/an/an/a15.5×n/a0.0×1.67
CytomX Therapeutics, Inc. · NASDAQ:CTMXUS$442.5MUS$98.96Mn/a7.0×n/a1.6×−609.0%0.0×1.21
Capricor Therapeutics, Inc. · NASDAQ:CAPRUS$441.3MUS$335.9Mn/an/an/a2.1×n/a0.4×0.94
Hansa Biopharma AB · OMXSTO:HNSAUS$440.3MUS$487.4Mn/a26.3×n/an/a−406.5%n/an/a
Shanghai MicuRx Pharmaceutical Co., Ltd. Class A · SSE:688373US$438.3MUS$407.2Mn/a16.2×n/a19.4×−57.0%0.9×n/a
Hyundai Bioscience Co. Ltd. · KRX:048410US$437.9MUS$411.3Mn/a166×n/a5.7×−861.5%0.1×n/a
Median of the othersUS$443.8MUS$298.2M16.2×2.2×−406.5%0.0×1.16

Team and board

OfficerRole
Heeyong LeeCEO
Mark TracyPresident of Tracy BioConsulting
Eunyoung SeolHead of R&D

Decks

DeckKindSlidesDate
Investor Presentation (April 2026)Investor deck25 slidesApr 20, 2026

Open Decks

Financials

Annual, in KRW

Income statement

LineFY2025FY2024
Revenue423.1M768.9M
Cost of revenue456.6M578.6M
Gross profit-33.5M190.3M
Research and development8.09B7.67B
Selling, general and administrative1.31B1.00B
Operating income-12.2B-10.8B
Depreciation and amortization1.60B1.83B
EBITDA-10.6B-8.93B
Interest expense707.1M2.44B
Income before tax-12.1B-83.3B
Net income-12.1B-83.3B
Earnings per share, basic-736.11-5,172.03

Balance sheet

LineFY2025FY2024
Cash and equivalents7.98B10.0B
Short-term investments44.2B16.2M
Receivables416.8M36.7M
Current assets53.3B10.7B
Total assets67.7B25.3B
Current liabilities7.25B141.7B
Long-term debt916.7M1.42B
Total liabilities9.41B144.9B
Shareholders' equity58.3B-119.5B
Shares outstanding16.4M16.1M

Cash flow

LineFY2025FY2024
Cash from operations-13.9B-7.97B
Capital spending-324.0M-583.7M
Free cash flow-14.2B-8.55B
Change in cash-2.04B-1.63B

Open Financials

Cap table

Built by 6ix from G2GBIO, Inc.’s releases

Common shares
16,629,426
Fully diluted
16,629,426

Fully diluted

LineShares
Common shares16,629,426

Share count over time

CountShares
Nov 22, 202616,629,426

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund191KUS$3.58MJul 31, 2026
Vanguard Developed Markets Index Fund128KUS$3.46MJun 30, 2026
Schwab International Small-Cap Equity ETF23,349US$902KMay 31, 2026
Vanguard Pacific Stock Index Fund12,670US$238KJul 31, 2026
Vanguard Total World Stock Index Fund8,954US$168KJul 31, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF7,117US$190KJun 30, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about G2GBIO, Inc.